查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553569

基因面板市場規模、佔有率、趨勢分析報告：按產品/服務、按方法、按設計、按應用、按最終用途、按地區、細分市場預測，2024-2030

Gene Panel Market Size, Share & Trends Analysis Report By Product & Services (Test Kits, Testing Services), By Technique (Amplicon Based), By Design, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

基因面板市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球基因面板市場規模將達到87.3億美元，2024年至2030年複合年成長率為17.6%。

先天性疾病的增加和全球癌症患者數量的空前增加預計將推動市場的發展。染色體異常的早期診斷可以預後診斷和治療措施，從而可以延緩症狀並提高生活品質。

此外，對遺傳性、基因篩檢、個人化醫療、風險分析和預後預測的日益成長的需求預計將推動市場的發展。為了了解疾病的遺傳傾向，需要對特定的基因簇進行定序和分析。此面板有助於確定已知導致疾病的特定基因的序列。有許多針對特定條件的預先設計的面板，也可以自訂。人們也持續進行研究工作，開發新的基因組，以有效診斷各種遺傳疾病。

例如，INVIEW Liquid Biopsy Onco-profiling 是一個綜合癌症基因組，用於使用血液等液態生物檢體樣本進行測試。還可以根據您的具體要求自訂基因面板。例如，QIAseq 多模式自訂面板是一個可自訂的基因面板，可讓您從單一樣本輸入中分析變異 DNA、RNA 融合和基因表現模式。

COVID-19 大流行嚴重擾亂了有效醫療保健服務的提供，包括遺傳諮詢和基因檢測服務。在美國，正在努力確保恢復基因檢測，至少是胚胎著床前篩檢。但加強癌症基因篩檢也是世界各地癌症協會使命的一部分。

此外，許多研究人員和臨床醫生認為，迫切需要進行基因篩檢以降低遺傳性疾病的死亡率，因此預計在預測期內對基因組的需求將會增加。例如，在美國，出生時就需要對血液樣本進行某些遺傳、內分泌、代謝、聽力和嚴重先天性心臟疾病的篩檢。

基因組市場報告亮點

  • 按產品和服務分類，由於檢測套組可以為臨床醫生、研究人員和公眾帶來實際好處，檢測套組產業在 2023 年佔據最大佔有率。現成的試劑套件和自我管理的診斷試劑套件如今越來越流行。
  • 從技術上來說，由於結果的可靠性，基於雜合反應的方法正處於成長階段，但這種技術昂貴且耗時。基因組通常設計用於分析多個基因，而雜合反應技術非常適合這種基因組測試概念。
  • 按照設計，2023 年的市場將由預先設計的基因組主導。這是因為在診斷效用方面，預先設計的基因組優於可自訂的基因組。
  • 從應用來看，由於癌症患者數量的增加以及各國癌症篩檢建議的增加，預計癌症風險評估領域將在預測期內顯著成長。
  • 由於基因篩檢和早期癌症篩檢的需求增加、主要企業的存在、癌症盛行率上升以及新生兒篩檢建議的增加，北美將在 2023 年主導全球市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 基因組市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 基因組市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 基因組市場：按產品/服務分類的估計和趨勢分析

  • 細分儀表板
  • 基因組市場：2023 年和 2030 年按產品/服務分類的變化分析
  • 檢測套組
  • 測試服務

第5章 基因檢測市場：技術預估與趨勢分析

  • 細分儀表板
  • 基因組市場：2023 年和 2030 年技術變化分析
  • 基於擴增子的方法
  • 基於混合的方法

第6章 基因組市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 基因組合市場：最終用途變化分析，2023 年和 2030 年
  • 學術研究所
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第7章 基因組市場：按應用估計和趨勢分析

  • 細分儀表板
  • 基因組合市場：2023 年和 2030 年應用變化分析
  • 癌症風險評估
  • 先天性疾病的診斷
  • 藥物基因學
  • 其他用途

第8章基因組合市場：區域估計與趨勢分析

  • 2023 年及 2030 年基因組市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Agilent Technologies
    • Illumina Inc.
    • Qiagen Inc.
    • Eurofins Genomics
    • Thermo Fisher Scientific, Inc.
    • Foundation Medicine, Inc.
    • Guardant Health, Inc.
    • Cepheid
    • Bio-Rad Laboratories, Inc.
    • Personalis
簡介目錄
Product Code: GVR-4-68039-977-6

Gene Panel Market Growth & Trends:

The global gene panel market size is expected to reach USD 8.73 billion by 2030, registering to grow at a CAGR of 17.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. A rise in the number of congenital disorders, coupled with an unprecedented increase in the number of cancer cases across the globe, is anticipated to drive the market. Early diagnosis of chromosomal disorders enables timely prognosis and therapeutic steps to be taken so as to retard the symptoms and improve the quality of life.

Furthermore, an increase in hereditary level understanding and a rise in the need for genetic screening, personalized medicine, risk analysis, and prognostics are anticipated to drive the market. A specific group of genes needs to be sequenced and analyzed to understand the genetic predisposition of a disease condition. The panels help in sequencing specific genes that are known to be causative of the disease condition. There are many predesigned panels for particular disease conditions along with options for customization. There also have been consistent research efforts to devise novel gene panels to efficiently diagnose a wide spectrum of genetic disorders.

For instance, INVIEW Liquid Biopsy Onco-profiling is an all-inclusive comprehensive cancer gene panel for examination using liquid biopsy samples like blood. Customizable gene panels are also available that can be customized based on specific requirements. For instance, QIAseq multimodal custom panel is a customizable gene panel that is able to profile variant DNA, RNA fusion, and gene expression patterns from a single sample input.

The COVID-19 pandemic has significantly disrupted the delivery of effective healthcare services, including genetic counseling and genetic testing services. There are efforts across the U.S. to ensure re-igniting genetic testing, at least for pre-implantation screening. However, the ramping up of genetic screening for cancer has also become a part of the mission of cancer societies across the globe.

Moreover, many researchers and clinicians believe that there is a strong necessity for the enforcement of genetic screening procedures to bring down the mortality rate due to genetic disorders, and therefore there will be a rise in the demand for gene panels during the forecast period. For instance, all those born in the U.S. are compulsorily screened using a blood sample for certain genetic, endocrine, metabolic, hearing, and critical congenital heart disorders.

Gene Panel Market Report Highlights:

  • By products & services, the test kits segment held the largest share in 2023 due to the utilitarian benefits that a test kit could offer to clinicians, researchers, and the normal population. Ready-to-use kits and self-administrable diagnostic kits are increasingly trending these days
  • By technique, the hybridization-based approach is in the growth phase due to the reliability of outcomes, though the technique is expensive and time-consuming. Gene panels are usually designed for the analysis of several genes and the hybridization technique is conducive to this concept of gene panel testing
  • By design, predesigned gene panels dominated the market in 2023. This is because predesigned gene panels are preferred over customizable gene panels for diagnostic utility because predesigned panels are backed by research for outcome reliability
  • By application, the cancer risk assessment segment is expected to grow lucratively during the forecast period due to a rise in the number of cancer cases and increased recommendations for cancer screening across different countries
  • North America dominated the global market in 2023 owing to the increasing demand for genetic screening and early cancer screening, the presence of key players, the rising prevalence of cancer, and rising recommendations for newborn screening

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Gene Panel Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Gene Panel Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Gene Panel Market: Products & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Gene Panel Market: Products & Services Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Test Kits
    • 4.3.1. Test Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Testing Services
    • 4.4.1. Testing Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Gene Panel Market: Technique Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Gene Panel Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Amplicon Based Approach
    • 5.3.1. Amplicon Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hybridization Based Approach
    • 5.4.1. Hybridization Based Approach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Gene Panel Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Gene Panel Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospital & Diagnostic Laboratories
    • 6.4.1. Hospital & Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gene Panel Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Gene Panel Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Cancer Risk Assessment
    • 7.3.1. Cancer Risk Assessment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Diagnosis of Congenital Diseases
    • 7.4.1. Diagnosis of Congenital Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Pharmacogenetics
    • 7.5.1. Pharmacogenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Other Applications.
    • 7.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Gene Panel Market: Regional Estimates & Trend Analysis

  • 8.1. Gene Panel Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacifics
    • 8.4.1. Asia Pacific Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Gene Panel Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Agilent Technologies
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Illumina Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Qiagen Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Eurofins Genomics
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Foundation Medicine, Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Guardant Health, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Cepheid
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Bio-Rad Laboratories, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Personalis
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives